Berberine has been proven to significantly reduce hepatic fat content in rats with NAFLD by decreasing methylation of the MTTP (microsomal triglyceride transfer protein) promoter and mitigating the hepatic steatosis caused by a high-fat dietary regimen in rodent models [24]. Here, MTTP is linked to metabolic dysfunction-associated steatotic liver disease.